Publications

The public health value of the results of the studies carried out by Epimentis is evidenced by their publication in international peer-reviewed scientific journals as well as through presentations at medical conferences.

ControleQualité
Types of publications
Scientific Articles
Posters
Presentations
Therapeutic areas
Cancerology
Cardiology
Dermatology
Endocrinology
Gastro-enterology
Gynecology
Hematology
Infectiology/virology
Neurosciences
new area
Ophthalmology
Pediatrics
Pneumology
Psychiatrie
Rheumatology
Vaccination
Types
Therapeutic Adhesion
Matching
CER
Cost
Incidence/prevalence
Mortality
Persistence
Quality of care
Literature review
Drug use
Years
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Scientific Articles
Cardiology
Quality of care
2025
Profiles and outcomes of patients treated with oral anticoagulants for atrial fibrillation who experience bleeding events requiring hospitalization in France
Archives of Cardiovascular Diseases

Nicolas Danchin, Dominique Guitard-Dehoux, Mélanie Née, Manon Belhassen, Olivier Hanon, Isabelle Mahé, Philippe Gabriel Steg, Claire Marant Micallef

PubMed Download
Scientific Articles
Cardiology
Cost
CER
2025
Nationwide extrapolation of economic benefit of therapeutic innovation: a 10-year retrospective budget impact of direct oral anticoagulants introduction in France
Journal of Medical Economics

C. Guilmet, H. Lesage, F. E. Cotte , R. Moreau, C. Marant Micallef , M. Nee ,D. Guitard-Dehoux, M. Belhassen, N. Danchin

PubMed
Scientific Articles
Pediatrics
Pneumology
Cost
2025
Newborn Screening for Cystic Fibrosis Is Associated With the Lowest Healthcare Costs: A 10-Year Observational Follow-Up Study in France
Pediatric pulmonology

Erika Guyot, Floriane Deygas, Manon Belhassen, Marjorie Berard, Eric Van Ganse, Isabelle Sermet-Gaudelus, Sabrine Tiaiba, Jean-Christophe Dubus, Isabelle Durieu, Philippe Reix

PubMed Download
Scientific Articles
Neurosciences
Quality of care
2025
Management of patients with active relapsing-remitting or secondary progressive multiple sclerosis: A French real-world study based on claims data linked to a phase IV study
Multiple sclerosis and related diseases

Xavier Moisset, Grégoire Mercier, Manon Belhassen, Floriane Deygas, Alexandre Civet, David Pau, Laure Rolland, Guillaume Bourel, Sophie Larrieu, Clarisse Marchal

PubMed Download